ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO Entering Prime Of Life

May 31, 1991

NCCN Also to Warn Doctors. Amgen’s Pledges to Disclose Future Results.

February 23, 2007

Hawkins Persists In Attacks On NCI Despite Testimony Refuting Charges

November 13, 1981

Budget Manipulations “Wreaking Havoc,” Korn Tells NCAB; Legal Actions Being Considered

February 13, 1987

Combination Therapy Improves Survival For HIV+ Patients

February 24, 2006

In Brief: Hedlund To Head Prostate Cancer Coalition; USCF Forms Human Genetics Program

July 25, 1997